$MGNC
Mag Magna Corp

2024 Q4 Form 10-Q Financial Statement

#000194986424000026 Filed on December 11, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2024 Q3 2024 Q2
Revenue $16.04K $5.293K
YoY Change 1045.79%
Cost Of Revenue $9.339K $4.400K
YoY Change 567.07%
Gross Profit $6.702K $893.00
YoY Change 378.71%
Gross Profit Margin 41.78% 16.87%
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $27.08K $19.32K
YoY Change 282.9% 160.25%
Operating Profit -$11.03K -$14.03K
YoY Change -294.57% 88.95%
Interest Expense $2.00
YoY Change -60.0%
% of Operating Profit
Other Income/Expense, Net $2.00
YoY Change -60.0%
Pretax Income
YoY Change
Income Tax
% Of Pretax Income
Net Earnings -$11.03K -$14.03K
YoY Change 94.74% 89.06%
Net Earnings / Revenue -68.79% -264.99%
Basic Earnings Per Share $0.00 $0.00
Diluted Earnings Per Share
COMMON SHARES
Basic Shares Outstanding 5.829M shares 5.829M shares
Diluted Shares Outstanding 5.829M shares 5.829M shares

Balance Sheet

Concept 2024 Q4 2024 Q3 2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $8.057K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses $27.78K $1.500K $73.60K
Receivables
Other Receivables
Total Short-Term Assets $42.28K $1.500K $73.60K
YoY Change 1056800.0% 1530.84%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles $72.40K $76.94K $13.17K
YoY Change 362.94% 60.52%
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $72.40K $76.94K $13.17K
YoY Change 259.85% -23.45%
TOTAL ASSETS
Total Short-Term Assets $42.28K $1.500K $73.60K
Total Long-Term Assets $72.40K $76.94K $13.17K
Total Assets $114.7K $78.44K $86.77K
YoY Change 469.87% 299.52%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $12.10K $12.22K $12.45K
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $170.8K $123.5K $117.8K
YoY Change 266.28% 235.31%
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $170.8K $123.5K $117.8K
Total Long-Term Liabilities
Total Liabilities $170.8K $123.5K $117.8K
YoY Change 266.28% 235.31%
SHAREHOLDERS EQUITY
Retained Earnings -$93.83K -$82.80K -$68.77K
YoY Change 617.08% -483.8%
Common Stock $37.73K $37.73K $5.829K
YoY Change 738.36% 29.53%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$56.10K -$45.07K -$31.04K
YoY Change
Total Liabilities & Shareholders Equity $114.7K $78.44K $86.77K
YoY Change 469.87% 299.52%

Cashflow Statement

Concept 2024 Q4 2024 Q3 2024 Q2
OPERATING ACTIVITIES
Net Income -$11.03K -$14.03K
YoY Change 94.74% 89.06%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$562.00
YoY Change -91.53%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $562.00
YoY Change -91.53%
NET CHANGE
Cash From Operating Activities -$562.00
Cash From Investing Activities
Cash From Financing Activities $562.00
Net Change In Cash
YoY Change
FREE CASH FLOW
Cash From Operating Activities -$562.00
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2025
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--04-30
dei Document Type
DocumentType
10-Q
dei Entity Central Index Key
EntityCentralIndexKey
0001949864
CY2024Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
usd
CY2024Q2 us-gaap Accounts Receivable Net
AccountsReceivableNet
usd
CY2024Q2 us-gaap Deferred Income Current
DeferredIncomeCurrent
usd
CY2023Q4 us-gaap Other Cost Of Operating Revenue
OtherCostOfOperatingRevenue
usd
us-gaap Other Cost Of Operating Revenue
OtherCostOfOperatingRevenue
usd
CY2024Q4 us-gaap Interest Expense
InterestExpense
usd
CY2024Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
usd
us-gaap Deferred Income Revenue Recognized
DeferredIncomeRevenueRecognized
usd
us-gaap Proceeds From Sale Of Intangible Assets
ProceedsFromSaleOfIntangibleAssets
usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
usd
us-gaap Interest Paid
InterestPaid
usd
us-gaap Interest Paid
InterestPaid
usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
usd
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-10-31
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
333-268561
dei Entity Registrant Name
EntityRegistrantName
MAG MAGNA CORP
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
WY
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
98-1626237
dei Entity Address Address Line1
EntityAddressAddressLine1
325 W Washington St Ste 2877
dei Entity Address City Or Town
EntityAddressCityOrTown
San Diego
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
92103
dei City Area Code
CityAreaCode
620
dei Local Phone Number
LocalPhoneNumber
4692043
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
No
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
5829047 shares
CY2024Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
8057 usd
CY2024Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
6444 usd
CY2024Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
27775 usd
CY2024Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
73600 usd
CY2024Q4 us-gaap Assets Current
AssetsCurrent
42276 usd
CY2024Q2 us-gaap Assets Current
AssetsCurrent
73600 usd
CY2024Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
72399 usd
CY2024Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
13172 usd
CY2024Q4 us-gaap Other Assets
OtherAssets
72399 usd
CY2024Q2 us-gaap Other Assets
OtherAssets
13172 usd
CY2024Q4 us-gaap Assets
Assets
114675 usd
CY2024Q2 us-gaap Assets
Assets
86772 usd
CY2024Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
12099 usd
CY2024Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
12447 usd
CY2024Q4 us-gaap Deferred Income Current
DeferredIncomeCurrent
19388 usd
CY2024Q4 us-gaap Loans Payable Current
LoansPayableCurrent
139292 usd
CY2024Q2 us-gaap Loans Payable Current
LoansPayableCurrent
105369 usd
CY2024Q4 us-gaap Liabilities Current
LiabilitiesCurrent
170779 usd
CY2024Q2 us-gaap Liabilities Current
LiabilitiesCurrent
117816 usd
CY2024Q4 us-gaap Liabilities
Liabilities
170779 usd
CY2024Q2 us-gaap Liabilities
Liabilities
117816 usd
CY2024Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000 shares
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000 shares
CY2024Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5829047 shares
CY2024Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5829047 shares
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5829047 shares
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5829047 shares
CY2024Q4 us-gaap Common Stock Value
CommonStockValue
5829 usd
CY2024Q2 us-gaap Common Stock Value
CommonStockValue
5829 usd
CY2024Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
31897 usd
CY2024Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
31897 usd
CY2024Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-93830 usd
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-68770 usd
CY2024Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
56104 usd
CY2024Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
31044 usd
CY2024Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
114675 usd
CY2024Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
86772 usd
CY2024Q4 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
9339 usd
CY2023Q4 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1400 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
13739 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1400 usd
CY2024Q4 us-gaap Other Cost Of Operating Revenue
OtherCostOfOperatingRevenue
6702 usd
us-gaap Other Cost Of Operating Revenue
OtherCostOfOperatingRevenue
7595 usd
CY2024Q4 us-gaap Revenues
Revenues
16041 usd
CY2023Q4 us-gaap Revenues
Revenues
1400 usd
us-gaap Revenues
Revenues
21334 usd
us-gaap Revenues
Revenues
1400 usd
CY2024Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
27075 usd
CY2023Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7071 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
46396 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
14496 usd
CY2024Q4 us-gaap Operating Expenses
OperatingExpenses
27075 usd
CY2023Q4 us-gaap Operating Expenses
OperatingExpenses
7071 usd
us-gaap Operating Expenses
OperatingExpenses
46396 usd
us-gaap Operating Expenses
OperatingExpenses
14496 usd
CY2024Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-11034 usd
CY2023Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-5671 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-25062 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-13096 usd
CY2023Q4 us-gaap Interest Expense
InterestExpense
5 usd
us-gaap Interest Expense
InterestExpense
2 usd
us-gaap Interest Expense
InterestExpense
11 usd
CY2023Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
5 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
11 usd
CY2024Q4 us-gaap Profit Loss
ProfitLoss
-11034 usd
CY2023Q4 us-gaap Profit Loss
ProfitLoss
-5666 usd
us-gaap Profit Loss
ProfitLoss
-25060 usd
us-gaap Profit Loss
ProfitLoss
-13085 usd
CY2024Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2023Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2024Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5829047 shares
CY2023Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4500000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5829047 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4500000 shares
CY2023Q2 us-gaap Shares Issued
SharesIssued
4500000 shares
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-13417 usd
us-gaap Net Income Loss
NetIncomeLoss
-13085 usd
CY2024Q2 us-gaap Shares Outstanding
SharesOutstanding
5829047 shares
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-31044 usd
us-gaap Net Income Loss
NetIncomeLoss
-25060 usd
CY2023Q3 us-gaap Shares Issued
SharesIssued
4500000 shares
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-20836 usd
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
-5666 usd
CY2023Q4 us-gaap Shares Issued
SharesIssued
4500000 shares
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-26502 usd
CY2024Q3 us-gaap Shares Outstanding
SharesOutstanding
5829047 shares
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
-45070 usd
CY2024Q4 us-gaap Net Income Loss
NetIncomeLoss
-11034 usd
CY2024Q4 us-gaap Shares Outstanding
SharesOutstanding
5829047 shares
CY2024Q4 us-gaap Stockholders Equity
StockholdersEquity
-56104 usd
mgnc Net Income
NetIncome
25060 usd
mgnc Net Income
NetIncome
13085 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
6875 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
1567 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-6446 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
20275 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-9000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
348 usd
us-gaap Deferred Income Revenue Recognized
DeferredIncomeRevenueRecognized
19388 usd
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-25866 usd
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-2518 usd
us-gaap Proceeds From Sale Of Intangible Assets
ProceedsFromSaleOfIntangibleAssets
9000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-9000 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
71202 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
12929 usd
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
37279 usd
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
1411 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
33923 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
11518 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
8057 usd
CY2024Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
8057 usd
CY2024Q4 mgnc Accumulated Deficit
AccumulatedDeficit
93830 usd
CY2024Q4 mgnc Netloss
Netloss
25060 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
25866 usd
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_846_eus-gaap--UseOfEstimates_zlXRLm3ByUV5" style="font: 12pt Times New Roman, Times, Serif; margin: 0"><i><span id="xdx_868_zNg0CjjpK5oi">Use of Estimates</span></i></p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
CY2024Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
84500 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
18400 usd
us-gaap Reclassifications
Reclassifications
<p id="xdx_840_eus-gaap--Reclassifications_zS1DDsswNhC2" style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><span id="xdx_865_zPeqjojkYXm1">Financial Statement Reclassification</span></i></p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Certain account balances from prior periods have been reclassified in these condensed financial statements to conform to current period classifications.</p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
CY2024Q4 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
139292 usd
CY2024Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5829047 shares
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5829047 shares
CY2024Q4 us-gaap Short Term Non Bank Loans And Notes Payable
ShortTermNonBankLoansAndNotesPayable
6470 usd

Files In Submission

Name View Source Status
0001949864-24-000026-index-headers.html Edgar Link pending
0001949864-24-000026-index.html Edgar Link pending
0001949864-24-000026.txt Edgar Link pending
0001949864-24-000026-xbrl.zip Edgar Link pending
ex31.htm Edgar Link pending
ex32.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
magna10q_31oct2024.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
magna10q_31oct2024_htm.xml Edgar Link completed
MetaLinks.json Edgar Link pending
mgnc-20241031.xsd Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
mgnc-20241031_lab.xml Edgar Link unprocessable
mgnc-20241031_def.xml Edgar Link unprocessable
mgnc-20241031_pre.xml Edgar Link unprocessable
mgnc-20241031_cal.xml Edgar Link unprocessable
report.css Edgar Link pending
Show.js Edgar Link pending